Zalevsky Jonathan - Insider Non-Derivative Transactions at NEKTAR THERAPEUTICS (NKTR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 22, 2025, Zalevsky Jonathan's relationship to NEKTAR THERAPEUTICS (NKTR) is Officer (Chief R&D Officer), and currently has 25,221 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NKTR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Zalevsky Jonathan - Insider Non-Derivative Transactions of NKTR Common Stock

Zalevsky Jonathan - Insider Non-Derivative Transactions at NKTR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 23, 2025	Acquisition -- (Common Stock)	6250	0	25221
Nov 26, 2025	Sell -- (Common Stock)	1157	54.28	18971
Nov 22, 2025	Acquisition -- (Common Stock)	2666	0	20128
Sep 5, 2025	Sell -- (Common Stock)	307	35.69	17462
Sep 5, 2025	Sell -- (Common Stock)	189	34.41	17769
Sep 5, 2025	Sell -- (Common Stock)	432	33.6	17958
Sep 5, 2025	Sell -- (Common Stock)	793	32.43	18390
Sep 3, 2025	Sell -- (Common Stock)	485	30.1	19183
Aug 20, 2025	Sell -- (Common Stock)	725	26.59	19668
May 20, 2025	Sell -- (Common Stock)	10712	0.67	305892
Feb 20, 2025	Sell -- (Common Stock)	10300	1.01	316604
Dec 20, 2024	Sell -- (Common Stock)	51115	0.94	326904
Dec 14, 2024	Acquisition -- (Common Stock)	135000	0	378019
Nov 20, 2024	Sell -- (Common Stock)	7785	1.01	243019
Aug 20, 2024	Sell -- (Common Stock)	6866	1.28	250804
May 18, 2024	Sell -- (Common Stock)	7355	1.75	257670
Feb 21, 2024	Sell -- (Common Stock)	9014	0.68	265025
Nov 18, 2023	Sell -- (Common Stock)	9646	0.49	274039
Aug 17, 2023	Sell -- (Common Stock)	9703	0.78	283685
May 17, 2023	Sell -- (Common Stock)	9791	0.72	293388
Feb 17, 2023	Sell -- (Common Stock)	10484	3	303179